Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
NBP
Strong SellSinkerNovaBridge Biosciences · Healthcare · United States · $213M · Avg Vol: $417K/d
10
StockRankGet insider-trade alerts
Q
34
V
34
M
16
P/E (TTM)
—
ROE
-59.1%
D/E
0.0x
Dividend %
—
COMPANY DESCRIPTION
NovaBridge Biosciences is a biotechnology company focused on the discovery and development of novel therapeutic candidates, likely targeting specific diseases with unmet medical needs. The company's competitive position hinges on the innovation of its drug pipeline and the potential for its proprietary compounds to address significant medical challenges.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | -1.6M | 0.6M | 0 | 0 | — | — | — | — | — |
| EPS | -4.82 | -4.24 | -2.33 | -0.28 | -0.40 | — | -0.69 | -0.94 | -1.06 | — |
| Shares | — | 190.9M | 185.6M | 187.5M | 115.6M | -39.4% | 115.6M | — | — | — |
| Debt | — | 10.9M | 3.9M | 3.9M | 3.1M | -34.4% | 4.5M | — | — | — |
| Equity | — | 421.8M | 242.6M | 201.2M | 230.9M | -18.2% | — | — | — | — |
| Op CF | — | -49.6M | -72.7M | -52.7M | -20.6M | — | -45.7M | — | — | — |
| Inv CF | — | -5.2M | -15.2M | -136.0M | 105.0M | — | — | — | — | — |
| Fin CF | — | 3.9M | -8.2M | -0.3M | 57.7M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+3.0%
SMA 50SMA 200
Close
$1.69
RSI (14)
33.3
52W High
$6.79
From 52W High
0.2%
SCORE BREAKDOWN
Quality
34
ROIC
-40.4%19.5
ROE
-59.1%15.9
GP/Assets
—N/A
Op. Margin
0.0%38.1
FCF/Assets
-7.9%31.9
Piotroski
321.9
Int. Cover
—N/A
D/E Ratio
0.02x79.1
Current Ratio
7.64x82.6
Value
34
P/E (TTM)
—N/A
EV/EBITDA
-0.2x25.0
P/FCF
—N/A
P/B
1.0x84.5
P/S
—N/A
Div Yield
—N/A
Momentum
16
52W High %
25%5.5
RS 6M
-60%8.6
SMA 50/200
0.69x7.2
EPS Rev 4W
0.0%34.4
EPS Rev 12W
0.0%41.6
EPS Improve
-54%9.1
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$213M
P/E (Forward)
-1.7x
Gross Margin
—
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of NBP are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| NBP | NovaBridge Biosciences(you) | $213M | 10 | Strong Sell |
| TARA | Protara Therapeutics, Inc. | $226M | 9 | Strong Sell |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $211M | 7 | Strong Sell |
| RNA | Atrium Therapeutics, Inc. | $233M | 11 | Strong Sell |
| NERV | Minerva Neurosciences, Inc. | $231M | 12 | Strong Sell |
| ABOS | Acumen Pharmaceuticals, Inc. | $211M | 13 | Strong Sell |
| CAMP | CAMP4 THERAPEUTICS CORPORATION | $260M | 10 | Strong Sell |
| PEPG | PepGen Inc. | $213M | 14 | Strong Sell |
| CHRS | Coherus Oncology, Inc. | $218M | 14 | Strong Sell |
| VYGR | Voyager Therapeutics, Inc. | $218M | 14 | Strong Sell |
Peer medians: ROE -30.2% · P/E 27.0x · Gross margin 58.3%